Largest Biotechnology Industry Companies
There are 646 Biotechnology companies.
All industries.
Total Market Cap: $1.19T
Rank | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (646 stocks) | +8.47% | 20.86 | 16.03 | 0.26 | -1.98% | 5.00% | +56.62% | +10.77% | 0.90 | |||||
51 | BLTE | Belite Bio Inc | $138.16 | $5.37B | +24.69% | N/A | 227.27 | N/A | -0.69% | N/A | 81 | +52.36% | $211 | 0.00% | 0.54 |
52 | COGT | Cogent Biosciences Inc | $33.10 | $5.36B | -15.32% | N/A | N/A | N/A | -5.34% | N/A | 75 | +63.90% | $54 | +29.44% | 1.74 |
53 | SRRK | Scholar Rock Holding Corp | $44.18 | $5.25B | +5.29% | N/A | N/A | N/A | -5.79% | N/A | 79 | +34.25% | $59 | +6.62% | 0.69 |
54 | APLS | Apellis Pharmaceuticals Inc | $41.03 | $5.25B | N/A | 39.02 | 46.30 | N/A | 0.71% | N/A | N/A | N/A | N/A | -7.96% | N/A |
55 | LGND | Ligand Pharmaceuticals Inc - Class B | $255.54 | $4.97B | +26.59% | 31.77 | 28.65 | 1.53 | 2.47% | N/A | 80 | +8.63% | $278 | +15.74% | 0.99 |
56 | XENE | Xenon Pharmaceuticals Inc | $52.10 | $4.96B | +40.27% | N/A | N/A | N/A | -6.19% | N/A | 78 | +54.63% | $81 | +23.01% | 0.95 |
57 | CAI | Caris Life Sciences Inc - Class A | $17.97 | $4.85B | N/A | N/A | 47.39 | N/A | 2.55% | N/A | 73 | +54.87% | $28 | 0.00% | 1.52 |
58 | CGON | Cg Oncology Inc | $59.56 | $4.83B | N/A | N/A | N/A | N/A | -3.32% | N/A | 81 | +51.60% | $90 | 0.00% | 1.48 |
59 | CRSP | CRISPR Therapeutics AG | $49.80 | $4.77B | +2.10% | N/A | 23.36 | N/A | -8.42% | N/A | 68 | +67.71% | $84 | -17.30% | 1.46 |
60 | FOLD | Amicus Therapeutics Inc | $14.49 | $4.50B | -39.28% | N/A | 30.49 | N/A | 0.66% | N/A | N/A | N/A | N/A | +6.41% | N/A |
61 | AKRO | Akero Therapeutics Inc | $54.65 | $4.38B | +23.96% | N/A | N/A | N/A | -5.71% | N/A | N/A | N/A | N/A | +13.53% | N/A |
62 | TVTX | Travere Therapeutics Inc | $52.04 | $4.32B | -44.12% | N/A | 71.43 | N/A | 0.90% | N/A | 76 | +7.88% | $56 | +27.44% | 1.29 |
63 | CELC | Celcuity Inc | $88.55 | $4.27B | +36.83% | N/A | N/A | N/A | -4.05% | N/A | 79 | +81.92% | $161 | +27.37% | 1.10 |
64 | DNTH | Dianthus Therapeutics Inc | $82.07 | $4.17B | N/A | N/A | N/A | N/A | -3.12% | N/A | 75 | +55.56% | $128 | 0.00% | 1.16 |
65 | ERAS | Erasca Inc | $14.05 | $4.16B | N/A | N/A | N/A | N/A | -2.20% | N/A | 70 | +49.47% | $21 | 0.00% | 1.35 |
66 | TNGX | Tango Therapeutics Inc | $30.94 | $4.13B | N/A | N/A | N/A | N/A | -3.45% | N/A | 68 | +30.74% | $40 | +23.09% | 1.39 |
67 | CPRX | Catalyst Pharmaceuticals Inc | $31.36 | $3.83B | +20.98% | 17.36 | 12.90 | 1.72 | 5.44% | N/A | 54 | +4.43% | $33 | +40.10% | 0.87 |
68 | ACAD | Acadia Pharmaceuticals Inc | $21.09 | $3.64B | N/A | 9.62 | 60.98 | 0.16 | 3.12% | N/A | 72 | +50.07% | $32 | -4.99% | 0.94 |
69 | CRNX | Crinetics Pharmaceuticals Inc | $34.47 | $3.61B | +16.22% | N/A | N/A | N/A | -11.61% | N/A | 78 | +141.20% | $83 | +12.72% | 1.15 |
70 | EWTX | Edgewise Therapeutics Inc | $34.83 | $3.54B | N/A | N/A | N/A | N/A | -4.21% | N/A | 77 | +32.30% | $46 | +6.00% | 1.39 |
71 | NAMS | NewAmsterdam Pharma Company NV | $30.40 | $3.42B | N/A | N/A | N/A | N/A | -4.15% | N/A | 78 | +64.24% | $50 | 0.00% | 1.02 |
72 | DNLI | Denali Therapeutics Inc | $21.66 | $3.27B | N/A | N/A | N/A | N/A | -12.91% | N/A | 75 | +56.65% | $34 | -22.01% | 1.54 |
73 | VKTX | Viking Therapeutics Inc | $28.75 | $3.22B | +47.58% | N/A | N/A | N/A | -10.58% | N/A | 78 | +222.02% | $93 | +36.44% | 1.58 |
74 | ORKA | ARCA biopharma Inc | $69.89 | $3.21B | +11.91% | N/A | N/A | N/A | -2.84% | N/A | 78 | +103.42% | $142 | +19.70% | N/A |
75 | TLX | Telix Pharmaceuticals Ltd | $9.56 | $3.20B | N/A | 135.58 | 2000.00 | N/A | -1.06% | N/A | 75 | +116.42% | $21 | 0.00% | 0.90 |
76 | BEAM | Beam Therapeutics Inc | $29.03 | $3.03B | -36.45% | N/A | N/A | N/A | -12.67% | N/A | 73 | +75.92% | $51 | -20.59% | 1.81 |
77 | GPCR | Structure Therapeutics Inc | $42.93 | $2.95B | N/A | N/A | N/A | N/A | -5.39% | N/A | 79 | +143.63% | $105 | 0.00% | 0.88 |
78 | DYN | Dyne Therapeutics Inc | $18.19 | $2.92B | N/A | N/A | N/A | 0.19 | -15.19% | N/A | 76 | +110.28% | $38 | -2.78% | 1.81 |
79 | ARQT | Arcutis Biotherapeutics Inc | $24.38 | $2.90B | -58.89% | N/A | 136.99 | N/A | 0.93% | N/A | 78 | +42.00% | $35 | -3.46% | 1.27 |
80 | RCUS | Arcus Biosciences Inc | $23.80 | $2.78B | +14.36% | N/A | N/A | N/A | -17.61% | N/A | 68 | +50.21% | $36 | -0.62% | 1.54 |
81 | SLNO | Soleno Therapeutics Inc | $53.01 | $2.74B | N/A | 29.02 | 13.12 | N/A | 3.85% | N/A | N/A | N/A | N/A | +25.17% | N/A |
82 | TARS | Tarsus Pharmaceuticals Inc | $61.95 | $2.64B | N/A | N/A | 106.38 | N/A | -1.20% | N/A | 77 | +51.91% | $94 | +11.84% | 0.65 |
83 | IRON | Disc Medicine Inc | $67.99 | $2.57B | N/A | N/A | N/A | N/A | -7.84% | N/A | 76 | +48.68% | $101 | -9.77% | 1.17 |
84 | RLAY | Relay Therapeutics Inc | $14.81 | $2.55B | N/A | N/A | N/A | N/A | -8.36% | N/A | 78 | +67.59% | $25 | -15.40% | 1.86 |
85 | ALMS | Alumis Inc | $24.15 | $2.51B | N/A | N/A | N/A | N/A | -15.03% | N/A | 77 | +66.05% | $40 | 0.00% | 0.87 |
86 | IDYA | Ideaya Biosciences Inc | $28.98 | $2.42B | +8.12% | N/A | 4.65 | N/A | -3.63% | N/A | 76 | +78.36% | $52 | +5.69% | 1.12 |
87 | ETNB | 89bio Inc | $14.84 | $2.34B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -5.20% | N/A |
88 | VERA | Vera Therapeutics Inc - Class A | $34.26 | $2.26B | N/A | N/A | N/A | N/A | -12.99% | N/A | 75 | +127.67% | $78 | +17.30% | 1.26 |
89 | RARE | Ultragenyx Pharmaceutical Inc | $24.35 | $2.26B | +15.22% | N/A | N/A | N/A | -22.24% | N/A | 78 | +113.76% | $52 | -25.04% | 1.00 |
90 | ELVN | Enliven Therapeutics Inc | $46.13 | $2.25B | -7.13% | N/A | N/A | N/A | -2.91% | N/A | 75 | +30.31% | $60 | +5.85% | 1.24 |
91 | DAWN | Day One Biopharmaceuticals Inc | $21.53 | $2.22B | N/A | N/A | N/A | N/A | -4.69% | N/A | N/A | N/A | N/A | +0.65% | N/A |
92 | MLYS | Mineralys Therapeutics Inc | $23.62 | $2.12B | N/A | N/A | N/A | N/A | -6.45% | N/A | 72 | +107.45% | $49 | 0.00% | 0.81 |
93 | PHVS | Pharvaris NV | $30.72 | $2.06B | +9.20% | N/A | N/A | N/A | -8.42% | N/A | 78 | +50.94% | $46 | +8.08% | 0.69 |
94 | IMNM | Immunome Inc | $18.38 | $2.06B | N/A | N/A | N/A | N/A | -10.00% | N/A | 80 | +94.61% | $36 | +1.37% | 1.68 |
95 | HRMY | Harmony Biosciences Holdings Inc | $34.46 | $2.05B | N/A | 14.05 | 10.93 | N/A | 16.65% | N/A | 63 | +28.73% | $44 | +1.49% | 0.67 |
96 | AUPH | Aurinia Pharmaceuticals Inc | $15.82 | $2.05B | N/A | 9.32 | 20.58 | 0.02 | 8.15% | N/A | 64 | +7.46% | $17 | +4.59% | 0.72 |
97 | MESO | Mesoblast Ltd | $13.93 | $2.02B | -10.27% | N/A | 454.55 | N/A | -3.01% | N/A | 91 | +151.26% | $35 | -3.72% | 1.43 |
98 | ADMA | Adma Biologics Inc | $8.21 | $1.97B | N/A | 12.13 | 10.02 | N/A | 5.48% | N/A | 68 | +114.37% | $18 | +34.87% | 1.20 |
99 | CLDX | Celldex Therapeutics Inc | $31.27 | $1.95B | +21.48% | N/A | N/A | N/A | -11.58% | N/A | 76 | +86.86% | $58 | +0.41% | 1.16 |
100 | KOD | Kodiak Sciences Inc | $34.06 | $1.95B | +4.23% | N/A | N/A | N/A | -7.59% | N/A | 75 | +84.00% | $63 | -16.69% | 1.75 |